The Problem of Timeliness of Young Children Vaccination and Ways to Solve It

Relevance Aims. Despite of widespread achievements and maintenance of appropriate levels of coverage of preventive vaccinations (>95%) the problem of delayed immunizations and vaccination on time is still existed in the Russian Federation over the last years. Materials and methods.  A selective analysis of the vaccination on time against diphtheria, tetanus, pertussis and hepatitis B, of children aged under 2 years in Russia, Moscow, from 2014 to 2018 was conducted. To assess the timeliness of vaccination, two independent sample studies were conducted: the vaccination history of 6003 whooping cough patients in Moscow was analyzed and vaccination was evaluated in 641 children, who were born 2016–2018  in Kirov, depending on the implementation of combination vaccines.  Results.  The current  95% coverage  of preventive  age-recommended vaccination  of decreed  age against  pertussis, diphtheria, tetanus, polio, hepatitis B is achieved only by 2–3 years of age. Conducted analysis showed, that the implementation of combination vaccines contributed  to increase in the proportion  of timely vaccinated children up to 1 year of age as well as propotion of children who started primary immunization series at recommended age of 3 months. Also as a result the vaccination coverage against Hib infection and proportion of timely vaccinated against pneumococcal infection was increased. Conclusions.The implementation of modern multicomponent combination vaccines allows to increase vaccination coverage in population and to control effectively infectious diseases and also to reduce number of injections and visits to clinics.

1. Briko N. I. Assessment of the quality and effectiveness of immunoprophylaxis. // Medical scientific and methodological portal «Attending physician». Available at: https://www.lvrach.ru/2012/10/15435557/ active on July 29, 2018. ((In Russ.).

2. Pertussis vaccines: WHO position paper, August 2015. Weekly Epidemiological Recommendations. 2015. Vol. 90, N 35. P. 433–460. (In Russ.).

3. Feldblum I. V. Modern problems of vaccination (scientific review). // Preventive and clinical medicine. 2017. No. 2 (63). P. 20–27. (In Russ.).

4. Ishmukhametov A. A., Dyakov I. N. National calendar of preventive vaccinations. Modern realities and prospects of development, Remedium. Journal of the Russian market of medicines and medical equipment, January–February 2014. P. 6–15. (In Russ.).

5. Stepenko A.V., Mindlina A.Ya. Risk management of the development of epidemiolofical whooping cough process: lost possibilities and new prospects, Medical almanac № 4 (49), 2017, P. 83–86 (In Russ.).

6. Global Health Observatory Data Repository. Available at http://apps.who.int/gho/data/node.main.ChildMortREG100?lang=en; accessed July 2015.

7. Happe LE, Lunacsek OE, Marshall GS et al. Combination vaccine use and vaccination quality in a managed care population. Am J Manag Care. 2007;13(9):506–512.

8. Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496–500. doi: 8.1097/INF.0b013e31805d7f17.

9. White C, Halperin SA, Scheifele DW. Pediatric combined formulation DTaP–IPV/Hib vaccine. Expert Rev Vaccines. 2009;8(7):831– 840. doi: 10.1586/erv.09.59.

10. Maman K, Zöllner Y, Greco D, et al. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132–2141. doi: 1080/21645515.2015.1044180.

11. Obando-Pacheco P, Rivero-Calle I, Gómez-Rial J, et al. New perspectives for hexavalent vaccines. Vaccine. 2018;36(36):5485– 5494. doi: 10.1016/j.vaccine.2017.06.063.